全球呼吸装置市场在2025年的价值超过29.56亿美元.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • Market Size (2025): USD 29.56 Billion
  • Market Size (2020): USD 43.87 Billion
  • CAGR (2026-2031): 6.98
  • Largest Market: Albania
  • Fastest Market: Andorra
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • More...

Market Analysis

The market for respiratory devices has experienced significant transformation, driven by the increasing prevalence of diseases, advancements in technology, and an aging demographic. From the initial use of mechanical ventilators in critical care settings to the rise of connected smart respiratory aids, the development of these devices shows a continual dedication to enhancing patient outcomes. Respiratory devices, which include ventilators, CPAP machines, nebulizers, oxygen therapy tools, and portable options, are crucial for treating chronic respiratory conditions and acute illnesses, such as pneumonia, influenza, and complications from COVID-19. Technological progress, like the application of artificial intelligence, Internet of Things features, and remote monitoring, has allowed healthcare providers to offer more accurate and tailored care. Global compliance regulations like ISO, FDA, and CE certifications guarantee the safety, quality, and compatibility of devices, promoting international trade and standardizing clinical practices. Research and development efforts are increasingly concentrating on smaller, mobile, and interconnected devices that are suitable for home healthcare, intensive care, and emergency situations. The respiratory devices market also showcases strategic partnerships among private entities, healthcare organizations, and governmental bodies aiming to address the growing demand for effective and scalable solutions in respiratory care. According to the research report, " Global Respiratory Devices Market Research Report, 2031," published by Actual Market Research, the Global Respiratory Devices market was valued at more than USD 29.56 Billion in 2025. The respiratory devices market has witnessed considerable growth recently, spurred on by the increasing rates of chronic illnesses, an older population, and the continuous adoption of digital health solutions. The recovery after the pandemic and greater focus on respiratory health have sped up innovation, especially in creating portable, easy-to-use devices and solutions for home care. Key players like Medtronic, Philips, ResMed, GE Healthcare, and Fisher & Paykel lead in the industry by providing diverse devices, ranging from standard ventilators to sophisticated smart monitoring tools.

Growth opportunities are plentiful in-home healthcare, where devices that allow for ongoing monitoring and management from afar can enhance patient compliance and lower hospitalization rates. Furthermore, the growth of healthcare systems in developing countries, along with initiatives to enhance access to respiratory care, is opening up new markets for advanced respiratory devices. The uptake of AI-integrated and connected devices is transforming treatment methods, allowing healthcare providers to refine therapy approaches and act sooner in the course of diseases. With continuous technological breakthroughs, regulatory alignment, and increased investments in healthcare. The respiratory devices market is set for ongoing expansion, offering numerous possibilities for both established and new market entrants to grow their presence and improve patient care across various regions. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Increasing incidence of chronic respiratory disorders: Chronic respiratory conditions such as COPD, asthma, and sleep apnea are increasingly prevalent around the world. Factors like air pollution, smoking, job-related risks, and poor lifestyle choices are contributing to this rise. The expanding number of patients is boosting the need for diagnostic tools, treatment options, and respiratory monitoring devices. Healthcare facilities, outpatient clinics, and home care services are making investments in sophisticated technology. Timely diagnosis and treatment are essential for enhancing the outcomes for patients. The demand for devices that can be used in hospitals as well as in portable formats is steadily increasing.

• Aging population: The population is aging swiftly, leading to a greater share of elderly people who need ongoing respiratory assistance. The decline in lung performance that comes with aging raises the demand for ventilators, oxygen therapy, and other supportive equipment. Older patients frequently suffer from several al health issues, which further increases device demand. Healthcare systems everywhere are adjusting to changes in this population trend. Increased life expectancy and improved expectations for quality of life promise ongoing market expansion. Market Challenges

• High cost of advanced devices: The cost of modern respiratory equipment is high, making it difficult for emerging markets and low-income nations to access them. Hospitals might postpone the upgrade to newer technologies because of financial limitations. The high prices can hinder patients from obtaining home care devices, leading to lower overall adoption rates. Economic barriers create inequities in the availability of treatment options. Finding cost-effective solutions and securing government support are vital to addressing this issue.

• Regulatory and reimbursement complexities: The process for gaining approval for respiratory devices differs by nation and can take a long time. Reimbursement policies and coverage by insurance companies vary throughout different regions. Complicated regulations may delay the release of new products and decrease patient access. Manufacturers are required to adhere to rigorous standards for safety, quality, and effectiveness. Managing these complex requirements raises operational expenses and hinders market development. Market Trends

• Telehealth and remote monitoring integration: There is a growing trend of combining telehealth offerings with respiratory devices, enabling healthcare providers to keep track of patients from a distance. Devices can send immediate data regarding oxygen saturation, breathing rates, and adherence to treatment plans. This enhances patient health outcomes, minimizes the need for hospital visits, and aids in managing chronic conditions. Remote monitoring proves particularly advantageous for home care clients and those living in remote areas. The uptake of telehealth has increased due to technological progress and the ease it provides patients.

• Portable, non-invasive, and user-friendly devices: A movement towards smaller, more user-friendly devices for outpatient and home care is underway. Non-invasive tools, including CPAP apparatus and portable oxygen concentrators, lessen the reliance on hospitals. Designs that are easy to use promote adherence and enhance the quality of life for patients. The ability to take these devices on the go allows patients to manage their conditions while engaged in travel or work. This trend responds to the rising demand for ease and independence in healthcare.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Type Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Disease Indication Chronic Obstructive Pulmonary disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)
By End User Hospitals
Ambulatory Care Centers (ACCs)
Home care Settings
Other End User
North America
Europe
Asia-Pacific
South America
MEA



Monitoring devices are expanding at the quickest rate because of the increasing need for immediate patient observation, remote healthcare options, and greater acceptance of wearable and connected technologies.

Tracking tools are becoming the quickest expanding area in the respiratory equipment market, indicating a transition towards advanced and proactive health care options. The rise in respiratory illnesses, especially asthma, COPD, and sleep apnea, has led to a strong demand for ongoing and precise monitoring of patients' health statuses. Today's tracking tools, such as pulse oximeters, spirometers, and wearable respiratory monitors, allow users to check oxygen levels, lung performance, and other vital health metrics in real-time. The movement towards telehealth and remote observation has further sped up the use of these devices, as health professionals can monitor patients' respiratory health without the need for frequent trips to the hospital. Improvements in IoT, AI, and cloud-based health systems have also boosted the capability and reach of monitoring devices, enabling predictive analytics, tailored care, and prompt responses. Moreover, The significance of constant respiratory tracking, especially for individuals with weakened lung health, increasing the need for home-use monitoring tools. A growing awareness among patients and healthcare professionals about the advantages of early identification and preventive care also drives market expansion. The compact and easy-to-use design of current devices promotes acceptance in home care, hospitals, and remote monitoring environments. , the fusion of technological advancements, rising disease rates, and a trend toward remote healthcare makes tracking devices the fastest-growing area in the respiratory equipment market.

Sleep apnea is the most rapidly expanding segment because of growing awareness, increasing obesity levels, and the uptake of home-use continuous positive airway pressure CPAP machines.

Sleep apnea is becoming the quickest expanding disease indication within the respiratory devices sector, prompted by a rise in occurrence, greater awareness, and improvements in treatment technologies. This condition, which encompasses obstructive and central types of sleep apnea, is closely related to lifestyle elements like obesity, lack of physical activity, and an aging population factors that are increasing ly. Increased awareness of the health dangers linked to untreated sleep apnea, such as heart diseases, diabetes, and tiredness during the day, has resulted in more diagnoses and a greater use of respiratory devices. Devices like continuous positive airway pressure CPAP machines, auto-adjusting units, and sophisticated oral appliances are now commonly utilized in hospitals, sleep centers, and home care environments. Innovations in technology, which have led to quieter, smaller, and easier-to-use CPAP machines, have made it more practical and pleasant to receive therapy at home, greatly enhancing market acceptance. Furthermore, the growth of telemedicine and remote monitoring has enabled doctors to monitor patient compliance and effectiveness, rising the attractiveness of these devices. In developing nations, the increased accessibility of cost-effective devices and educational campaigns has broadened the patient demographic, propelling market expansion. The combination of increasing disease rates, heightened patient knowledge, government health initiatives, and swift technological progress solidifies sleep apnea's status as the fastest expanding disease indication in the respiratory devices sector.

Home care settings are the quickest expanding end-user segment because of the growing choice for home treatment, ease of use, and the increasing presence of portable and simple-to-use respiratory devices.

Home care environments are becoming the most rapidly expanding segment among users of respiratory devices. This growth is propelled by a move towards patient-focused care and a greater demand for ongoing management of chronic respiratory ailments. Individuals suffering from illnesses like COPD, asthma, and sleep apnea opt for treatments at home due to the ease, comfort, and fewer trips to hospitals. Advances in technology have led to the creation of portable, compact, and user-friendly devices like home oxygen concentrators, CPAP machines, nebulizers, and wearable monitoring gadgets, which aid in self-care and boost patient adherence. The use of home care solutions by showcasing the necessity of limiting hospital visits and reducing exposure risks. The integration of telemedicine and remote monitoring tools enables healthcare providers to observe patient health in real-time, facilitating effective disease management beyond hospital walls. The increasing elderly population, who often favors at-home care for managing chronic conditions, plays a major role in the growth of this market. Enhanced awareness regarding respiratory health, an uptick in insurance coverage for home healthcare services, and government initiatives encouraging home care further propel this movement. The combination of technological progress, patient ease, remote monitoring options, and rising awareness establishes home care environments as the fastest-growing user segment in the respiratory device market.

Market Regional Insights


North America excels in the respiratory devices market due to high rates of respiratory illnesses, developed healthcare systems, considerable research and development efforts, and the widespread use of advanced technological devices.

North America ranks as the top area in the market for respiratory devices, influenced by a mix of high rates of diseases, technological progress, and robust healthcare systems. Conditions like COPD, asthma, and sleep apnea are common here, caused by smoking, older populations, and pollution, leading to a significant need for respiratory tools. With one of the most advanced healthcare infrastructures on the planet, the area has hospitals and clinics ready to use cutting-edge therapeutic and monitoring devices. Ongoing investments in research and development from both government and private sectors guarantee the release of new, user-friendly respiratory tools, such as portable ventilators, modern CPAP machines, and intelligent monitoring systems. North America enjoys high per capita healthcare spending, beneficial reimbursement practices, and extensive insurance coverage, allowing patients to access respiratory devices for hospital and home use. Furthermore, the region has a strong regulatory system that allows for efficient approval and marketing of new devices, while effective distribution channels ensure they are available in both urban and semi-urban locations. The incorporation of technology, such as telehealth and remote patient tracking, has also sped up device usage, particularly in managing chronic illnesses and home care. Awareness initiatives and educational programs about respiratory health aid in increasing usage rates. The blend of advanced infrastructure, strong research and development strength, high disease rates, and favorable regulatory and reimbursement conditions establishes North America as the leading market for respiratory devices.

Key Developments


• In 2025: Vyaire Medical C funding round intended to speed up innovation and the market launch of next-gen respiratory care products.
This investment is anticipated to aid R&D efforts, broaden product lines, and bolster the company's competitive edge.

• In 2025: ResMed finalized the purchase of Ectosense, a firm focused on digital solutions for home sleep diagnostics.
This tactical decision boosts ResMed's digital offerings in respiratory and sleep healthcare by including advanced diagnostic tools, thereby enhancing remote patient management.

• In 2025: Fisher & Paykel Healthcare attained FDA approval for the Optiflow Airvo 3 System, a high-flow therapy device designed to improve respiratory assistance.
This innovation extends their range in humidified respiratory therapy for patients.

• In 2025: Hillrom unveiled a digital respiratory health platform in North America that mixes connected devices with remote monitoring to better handle chronic respiratory issues, merging telehealth with respiratory care technologies.

• In 2024: Medtronic latest portable oxygen concentrator gained FDA approval, allowing patients to access ongoing oxygen therapy at home, thereby increasing access to respiratory care beyond hospital settings.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • 7 . Stryker corporation
  • 8 . Siemens AG
  • 9 . GE Healthcare
  • 10 . Vapotherm Inc.

Table of Contents

  • Table 1: Global Respiratory Devices Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
  • Table 2: Influencing Factors for Respiratory Devices Market, 2025
  • Table 3: Top 10 Counties Economic Snapshot 2024
  • Table 4: Economic Snapshot of Other Prominent Countries 2022
  • Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 6: Global Respiratory Devices Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
  • Table 7: Global Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 8: Global Respiratory Devices Market Size and Forecast, By Therapeutic Devices (2020 to 2031F) (In USD Billion)
  • Table 9: Global Respiratory Devices Market Size and Forecast, By Monitoring Devices (2020 to 2031F) (In USD Billion)
  • Table 10: Global Respiratory Devices Market Size and Forecast, By Diagnosticc Devices (2020 to 2031F) (In USD Billion)
  • Table 11: Global Respiratory Devices Market Size and Forecast, By Consumables and Accessories (2020 to 2031F) (In USD Billion)
  • Table 12: Global Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 13: Global Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 14: North America Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 15: North America Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 16: North America Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 17: Europe Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 18: Europe Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 19: Europe Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 20: Asia-Pacific Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 21: Asia-Pacific Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 22: Asia-Pacific Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 23: South America Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 24: South America Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 25: South America Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 26: Middle East & Africa Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 27: Middle East & Africa Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 28: Middle East & Africa Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 29: Competitive Dashboard of top 5 players, 2025
  • Table 30: Key Players Market Share Insights and Analysis for Respiratory Devices Market 2025

  • Figure 1: Global Respiratory Devices Market Size (USD Billion) By Region, 2024 & 2030
  • Figure 2: Market attractiveness Index, By Region 2030
  • Figure 3: Market attractiveness Index, By Segment 2030
  • Figure 4: Global Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: Global Respiratory Devices Market Share By Region (2025)
  • Figure 6: North America Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 7: North America Respiratory Devices Market Share By Country (2025)
  • Figure 8: Europe Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 9: Europe Respiratory Devices Market Share By Country (2025)
  • Figure 10: Asia-Pacific Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 11: Asia-Pacific Respiratory Devices Market Share By Country (2025)
  • Figure 12: South America Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 13: South America Respiratory Devices Market Share By Country (2025)
  • Figure 14: Middle East & Africa Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 15: Middle East & Africa Respiratory Devices Market Share By Country (2025)
  • Figure 16: Porter's Five Forces of Global Respiratory Devices Market

Market Research FAQs

Major contributors include North America, Europe, Asia-Pacific, and other regions. North America leads due to a higher prevalence of respiratory diseases, while Asia-Pacific is a rapidly growing market with increasing awareness.
Challenges include high equipment costs, regulatory hurdles, the need for skilled healthcare professionals to operate devices, and ensuring patient compliance with treatment plans.
The market is expected to continue growing, driven by increasing respiratory diseases and an aging population, technological advancements, and a shift towards home-based care.
The Asia-Pacific region is anticipated to grow with more than 10% CAGR from 2023-2028.
Advancements in respiratory care devices can lead to improved patient outcomes, better management of chronic respiratory conditions, and enhanced patient comfort. Healthcare providers can offer more personalized and efficient care, while patients can enjoy a higher quality of life and increased independence in managing their respiratory health.
The market is propelled by the rise in chronic respiratory diseases, an aging population, increased environmental pollution, and a growing need for home-based and non-invasive respiratory care.
The main hurdles include the high costs of advanced devices, regulatory challenges, variable insurance coverage policies, and the underdiagnosis or low awareness of respiratory issues in numerous areas.
Significant trends involve the blending of telehealth and remote monitoring with respiratory devices, creation of portable and user-friendly tools, and a surge in R&D funding directed at innovative approaches.
Items such as ventilators, oxygen therapy devices, CPAP/BiPAP machines, nebulizers, and smart monitoring systems are highly sought after in hospitals, clinics, and homecare environments.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags